These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 20107323)
1. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323 [TBL] [Abstract][Full Text] [Related]
2. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Bockstaele L; Bisteau X; Paternot S; Roger PP Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459 [TBL] [Abstract][Full Text] [Related]
4. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Ray A; James MK; Larochelle S; Fisher RP; Blain SW Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005 [TBL] [Abstract][Full Text] [Related]
5. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892 [TBL] [Abstract][Full Text] [Related]
6. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. Coulonval K; Vercruysse V; Paternot S; Pita JM; Corman R; Raspé E; Roger PP Cell Cycle; 2022 Jan; 21(1):12-32. PubMed ID: 34913830 [TBL] [Abstract][Full Text] [Related]
10. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors. Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508 [TBL] [Abstract][Full Text] [Related]
12. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615 [TBL] [Abstract][Full Text] [Related]
14. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495 [TBL] [Abstract][Full Text] [Related]
15. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
16. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Haller K; Wu Y; Derow E; Schmitt I; Jeang KT; Grassmann R Mol Cell Biol; 2002 May; 22(10):3327-38. PubMed ID: 11971966 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. Paternot S; Coulonval K; Dumont JE; Roger PP J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225 [TBL] [Abstract][Full Text] [Related]
18. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668 [TBL] [Abstract][Full Text] [Related]
19. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Parry D; Mahony D; Wills K; Lees E Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865 [TBL] [Abstract][Full Text] [Related]
20. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Upton JW; van Dyk LF; Speck SH Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]